SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-237890
Filing Date
2021-08-05
Accepted
2021-08-05 17:06:26
Documents
17
Period of Report
2021-08-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d187235d8k.htm   iXBRL 8-K 38285
2 EX-3.1 d187235dex31.htm EX-3.1 6544
3 EX-5.1 d187235dex51.htm EX-5.1 9024
4 EX-10.1 d187235dex101.htm EX-10.1 196719
9 GRAPHIC g187235dsp3.jpg GRAPHIC 3944
  Complete submission text file 0001193125-21-237890.txt   490063

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tmb-20210805.xsd EX-101.SCH 3963
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20210805_def.xml EX-101.DEF 14678
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20210805_lab.xml EX-101.LAB 24398
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20210805_pre.xml EX-101.PRE 15776
10 EXTRACTED XBRL INSTANCE DOCUMENT d187235d8k_htm.xml XML 7016
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 211149349
SIC: 2834 Pharmaceutical Preparations